Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    nilotinib AND GIST | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Condition: GIST and CML
Intervention: Drug: AMN107
2 Recruiting A Global Imatinib and Nilotinib Pregnancy Exposure Registry
Condition: All Indications for Glivec/Gleevec and Tasigna
Interventions: Drug: Tasigna;   Drug: Gleevec

Indicates status has not been verified in more than two years